Beneficial Extracardiac Effects of Cardiovascular Medications

Asra K Butt1, Jay Patel2, Hamid Shirwany3

  • 1Department of Internal Medicine, Veteran Affairs Medical Center, Memphis, TN 38104, USA.

Current Cardiology Reviews
|November 15, 2021
PubMed

Insights

Cardiovascular medications offer surprising benefits beyond heart health. This review explores how common heart drugs, like minoxidil and sildenafil, are repurposed to treat non-cardiovascular conditions such as hair loss and erectile dysfunction.

Area of Science:

  • Pharmacology
  • Cardiology
  • Internal Medicine

Background:

  • Cardiovascular diseases are leading causes of mortality globally.
  • Cardiovascular medications are widely prescribed with diverse systemic effects.
  • Extracardiovascular effects of these drugs present therapeutic opportunities.

Purpose of the Study:

  • To review the non-cardiovascular applications of commonly prescribed cardiovascular medications.
  • To highlight the repurposing of cardiovascular drugs for various pathologies.

Main Methods:

  • Literature review of established cardiovascular drugs.
  • Analysis of documented extracardiovascular effects and their clinical uses.

Main Results:

  • Minoxidil (hypertension) treats alopecia.
  • Sildenafil (hypertension) treats erectile dysfunction.
  • Alpha-1 blockers, beta-blockers, calcium channel blockers, thiazides, and spironolactone have established non-cardiovascular uses.

Conclusions:

  • Common cardiovascular drugs possess significant extracardiovascular therapeutic potential.
  • Repurposing these medications offers novel treatment strategies for non-cardiovascular conditions.
  • Understanding these side effects expands their clinical utility.

Related Concept Videos

Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
481
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
1.1K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.4K
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
851
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
567
Exercise and Cardiac Output01:17

Exercise and Cardiac Output

Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be...
1.4K